Straight From the Cutter's Mouth
    CME 0.5 General AMA PRA Category 1 Credits™

    Drs. Priya Vakharia and Akshay Thomas join to discuss the October 2021 edition of Retinal Physician, found online at http://www.retinalphysician.com, with a focus on diabetic retinopathy. Discussion includes Diabetic Retinopathy, Trials, Focal Laser, and Crunch Effect of Anti-VEGF.

    Relevant Financial Disclosures:
    Dr. Sridhar is a consultant for Genentech, Regeneron, Allergan, Alcon, and Dorc. Dr. Thomas is a consultant for Allergan, Avesis, Novartis, and Zeiss. Dr. Vakharia is a consultant for Genentech and have honoraria for Bausch and Lomb.

    CME Information

    Release: October 5, 2021; expires October 5, 2024

    Reviewers: D. Wilkin Parke III, MD

    Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

    Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

    Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

    Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.